Związki wanadu i ich działanie przeciwcukrzycowe

• Autorzy: Wronska-Tyra J. , Pasternak K.
• Języki publikacji: PL

Abstrakty

PL

Badania dotyczące związków wanadu obecnie zmierzają w kilku kierunkach. Pierwszy - to ocena możliwości zastosowania odpowiednich, najmniej toksycznych, organicznych związków wanadu do leczenia cukrzycy typu I i II oraz prześledzenie dróg przenikania, oddziaływania i wydalania wanadu z organizmu. Drugi - to wpływ obniżonego poziomu wanadu na nasilenie się choroby wieńcowej i zawału serca, zwiększenie śmiertelności wśród pacjentów z przewlekłym nieżytem jelit, z zaburzeniami wchłaniania z przewodu pokarmowego. Trzeci kierunek zmierza do oceny efektów łączenia związków wanadu z innymi preparatami farmakologicznymi, ich działania synergistycznego i an- tagonistycznego. W pracy przedstawiono pierwszy kierunek badań nad związkami wanadu i ich przeciwcukrzycowym działaniem.

EN

The investigations concerning the vanadium compounds tend recently in several directions. The first of them is the estimation the ability the application of the least toxic, suitable, organic vanadium Compounds under treatment of diabetes I and II and the study on the ways of their influence, intake and excrection. The aim of the second one is to determine the relationships between the decreased organism vanadium level and the incident of the infact or the coronary arterial disease; the dependence between the increase mortality of the patients with the disturbance absorption from the alimentary also with the chronic enterocolitis and the vanadium level is also studied. The third one leads to the assessment of the effects of the combined treatment with the vanadium compounds and other pharmaceutical preparations and their synergistic and antagonistic action. In our paper we showed the first direction tested vanadium compounds and their antidiabetic influence.

Słowa kluczowe

PL

preparaty farmaceutyczne; choroby jelit; choroby czlowieka; choroby ukladu krazenia; wanad; dzialanie przeciwcukrzycowe; cukrzyca; leczenie; zwiazki wanadu

• Wydawca: -
• Czasopismo: Journal of Elementology
• Rocznik: 2003
• Tom: 08
• Numer: 2
• Opis fizyczny: s.111-119,bibliogr.

Twórcy

autor

Wronska-Tyra J.

• Akademia Medyczna, Lublin

autor

Pasternak K.

Bibliografia

• Barrio D.A., Braziunas M.D., Etchevery S.B., Cortizo A.M. 1997. Maltol Complex of Vanadium (IV) and (V) Regulate in Vitro Alkaline Phosphatase Activity and Osteoblast-like Cells Growth. J. Trace Elem. Med. Biol., 11(2): 110-115. Brichard S.M., Ongemba L.N., Kolanowski I., Henquin I.C. 1991. The Influence of Vanadate on
• Insulin Counter-Regulatory in Obese Fa/Fa Rats. J. Endocrinol., 131: 185-191.
• Brichard S.M., Lederer J., Henquin J.C. 1991. Insulin-like Properties of Vanadium: A Curiosity or Perspective for Treatment of Diabetes? Diabete and Metabolisme., 17(5): 435-440.
• Brichard S.M., Bailey C.J., Henquin J.C. 1990. Marked Improvement of Glucose Homeostasis in Diabetic Ob./Ob. Mice Given Oral Vanadate. Diabetes., 39: 1326-1332.
• Cam M.C., Li W.M., Mcneil J.H. 1997. Partial Preservation of Pancreatic Beta-cells by Vanadium: Evidence for Long-term Amelioration of. Diabetes., 46(7): 769-778.
• Cantley L.C., Aisen P. 1979. The Fate of Cytoplasmic Vanadium. J. Biol. Chem. 254: 1781-1784.
• Cantley L.C., Josepgson L., Warner R., Yanagisawa M., Lechene C., Guidotti G. 1977. Vanadate is a Potent (NalK)-ATP-ase Inhibitor Found in ATP-derived from Muscle., J. Biol. Chem. 252: 7421-7423.
• Cohen N., Halberstam M., Shlimivich P., Chang C. J., Shamoon H., Rosetti L. 1995. Oral Vanadyl Sulphate in Proves Hepatic and Peripheral Insulin Sensivity in Patient with Non-insulin Dependent Diabetes Mellitus. J. Clin. Invest., 95: 2501-2509.
• Crans D.C., Mahroof-Tahir M., Keramidas A.D. 1995. Vanadium Chemistry and Biochemistry of Relevance for Use of Vanadium Compounds as Antidiabetic Agent. Mol. Cell. Biochem., 153, 1-3: 17-24.
• Domingo I.L. 1996. Vanadium a Review of the Reproductive and Developmental Toxicity. Reprod. Toxicol., 10(3): 175-182 .
• Domingo I.L., Gomez M., Sanchez O.J., Llobet J.M., Keen C.L. 1995. Toxicology of Vanadium Compounds in Diabetic Rats: The Action of Chelating Agents on Vanadium Accumulation. Mol. Cell. Biochem., 153: 233-240.
• Donahue B.S., Morgan E.T. 1990. Effects of vanadate on hepatic cytochrome P-450 expresion in streptozotocin-diabetic rats. Drug Metabolism and Disposition the Biological Fate of Chemicals, 18: 519-526.
• Etchevery S.B., Crans D.C., Keramidas A.D., Cortizo A.M. 1997. Insulin-mimetic Action ofVanadium Compounds on Osteoblast-like. Cells in Culture. Arch. Biochem. Biophys.,338(1): 7-14.
• Green A. 1986. The Insulin-like Effect of Sodium Vanadate on Adipocyte Glucose Transport is Mediated at a Post -Insulin-Receptor Level. Biochem. J., 238: 663-669.
• Goldfine A B., Simonson D.C., Folli F., Patti M.E., Kahn C.R. 1995. In Vivo and in Vitro Studies of Vanadate in Human and Rodent Diabetes Mellitus. Mol. Cell. Biochem., 153(1-2): 217-231.
• Karczewski J. 1997. The Effect of Vanadium on the Content of Magnesium in Selected Organus of Rat Depending Type. Brom. Chem. Toksykol., 30(3): 233-239.
• Kiersztan A. 1998. Insulinopodobne działanie związków wanadu. Post. Biochem., 4(4): 275-282.
• Kordowiak A.M., Kapusta P., Trzos R., Dziewońska K. 1995. Cukrzyca modelowa jako narzędzie badania zmian występujących w cukrzycy klinicznej. Prostaglandyny i związki wanadu wnor- malizacji zmian cukrzycowych. Post. Biol. Kom., 22(5): 17-33.
• Lee J.D. 1999. Zwięzła chemia nieorganiczna. PWN, Warszawa.
• Leonard A., Gerber G.B. 1994. Mutagenicity, Carcinogenicity, Teratogenicity of Vanadium Compounds. Mutat. Res., 317: 81-88.
• Levy E., Bendayan M. 1991. Lipoprotein Lipase in Experimental Diabetic Rats: Beneficial Effect of Vanadate Treatment. Diabete et Metabolisme., 17: 44-48.
• Lewandowicz J. 1988. Wanad, alkohol, organizm człowieka. Problemy Alkoholizmu, 4: 7.
• Li J., Elberg G., Crans D.C., Shechter Y. 1996. Evidence for the Distinct Vanadyl VÍ+4J- Dependence Activiting System for Manifesting Insuline System. Biochemistry, 35: 8314-8318 .
• Meyerowitch J., Rothenber G.P., Schechter Y., Bonner-Weir S., Khan C.R. 1991 .Vanadate Normalizes Hyperglicemia in two Mouse Models of non-insulin-depende Diabetes Mellitus. J. Clin. Invest., 87: 1286-1294.
• Murray R., Granner D.K., Mayes P.A., Rodwell V.W. 1995. Biochemia Harpera. PZWL, Warszawa.
• Nechay B.R., Nannignga L.B., Nechay P.S.E., Post R.L., Grantham J.J., Macara I.G., Kuběna L.F., Philips T.D., Nielsen F.H. 1986. Role ofVanadium in Biology. Fed. Proc. 45: 123-132.
• Oberbeil K. 1996. Mikroelementy pierwiastki życia. Interart, Warszawa.
• Poucheret P., Verma S., Grynpas M. D., Mcneill J.H. 1998. Vanadium and Diabetes. Mol. Celi. Biochem., 188(1-2): 73-80.
• Pugazhenthi S., Khandelwal R.L., Angel I.T. 1991. Insulin-like effect of vanadate on malic enzyme and glocose-6-phosphate dehydrogenase activities in streptozotocin-induced diabetic rat liver. Biochim. Biophys, Acta, 1083: 310-312.
• Rosetti L., Lauglin M.R. 1989. Correction of Chronic hyperglycemia with Vanadate, but not with
• Phlorizin Normalizes in Vivo Glycogen Repletion and Vitro Glycogensynthase Activity in Diabetic Skeletal Muscle. J. Clin. Invest., 84: 892-899.
• Sakurai H., Shimomura S., Fukuzawa K., Ishizu K. 1980. Detection of Oxovanadium (VI) and Characterization of its Ligand Environment in Subcellular Fraction of the Liver of Rats Treated with Pentavalent Vanadium. Biochem. Biophys. Res. Commun., 96: 293-298.
• Sakurai H., Tsuchiya K., Nakatsuka M., Sofue M., Kawada J. 1990. Insuline-like Effect of Vanadyl Jon on Streptozotocin-induced Diabetic Rats. J. Endocrinol., 126: 451-459.
• Sekar N., Govindasamy S. 1991. Effect of Vanadate on Plasma Lipoprotein profiles in Experimental Diabetic Rats. Biochem. Int., 23: 935-940.
• Shechter Y., Karlish S.J.D. 1980. Insulin-like Stimulation of Glucose Oxidation in Rat Adipocytes by Vanadyl (TV) Ions. Nature, 284: 556-558.
• Srivastava P., Saxena A.K., Kale R.K., Baquer N.Z. 1993. Insulin-like Effects of Lithium and Vanadate on the Altered Antioxidant Status of Diabetic Rats. Res. Commun. Pathol. Pharmacol., 3: 283-293.
• Tatoń J. 1993. Diabetologia praktyczna. PZWL, Warszawa.
• Trzos R., Kordowiak A. 1994. Derivatives of Vanadium as Insulin-mimetic Agent in Diabetes. Post. Biol. Kom., 21(3): 293-302 .
• Venkatesan N., Aviden A., Davidson M. B. 1991. Antidiabetic Action of Vanadyl in Rats Independent of in Vivo Insulin-receptor Kinase Activity. Diabetes., 40: 492-498.
• Verma S., Cam M.C., Mcneill J.H. 1998. Nutritional Factors that Can Favorably Influence the Glucose/Insulin System Vanadium. J. Am. Coll. Nutr., 17(1): 11-18.
• Yao I., Battell M.L., Mcneill J.H. 1997. Acute and Chronic Response to Vanadium Following Two Methods of Streptozotocin Diabetes Induction. Can. J. Physiol. Pharmacol., 75( 2): 83-90.
• Zaporowska H., Wasilewski W. 1992. Combined Effect of Vanadium and Zinc on Certain Selected Haematological Indices in Rats. Comp. Biochem. Physiol., C 103 (C ) 1: 143-147.
• Zaporowska H. 1995. Rola wanadu w metabolizmie komórki zwierzęcej. Post. Biol. Kom., 22:149-165.